CASE COMMENT: UNILATERAL PRACTICE - ABUSE OF DOMINANCE - INTELLECTUAL PROPERTY

Abusive use of administrative procedures: The Commission sanctions for the first time on the basis of article 82 EC an abusive use of administrative and regulatory procedures (AstraZeneca)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. Last Wednesday, 15 June 2005, the Commission adopted a decision important, at least in principle, in that it This is the first decision in which it explicitly applies of Article 82 EC for misuse of procedures administrative and regulatory requirements. In the United States, certain courts and the Federal Trade Commission have already issued decisions qualifying violations of antitrust law before patent offices and misuse of procedures regulatory requirements for drug approvals. Thus, there is no need to misuse rights of intellectual property to prevent or delay the arrival of competitors in the market and thus maintain the price of its

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • L’actu-concurrence (Paris)

Quotation

Alain Ronzano, Abusive use of administrative procedures: The Commission sanctions for the first time on the basis of article 82 EC an abusive use of administrative and regulatory procedures (AstraZeneca), 15 June 2005, Concurrences N° 3-2005, Art. N° 63310, www.concurrences.com

Visites 95

All reviews